Back to Search
RICHARD MEREDITH, MD
MD
Cardiovascular Disease Physician
NPI: 1518303569IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
13150074-1205(UT)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor response.
PMID 11915176·Cancer Biother Radiopharm·2002
6-review
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
PMID 11603001·Cancer Biother Radiopharm·2001
3-trial
The photography of neonatal bereavement at Wythenshawe Hospital.
PMID 11271864·J Audiov Media Med·2000
8-other
Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
PMID 19467801·Int J Radiat Oncol Biol Phys·2010
8-other
Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer.
PMID 19386438·Int J Radiat Oncol Biol Phys·2010
8-other
Finite element analysis of the middle ear transfer functions and related pathologies.
PMID 19643654·Med Eng Phys·2009
6-review
A phylogeny of Diprotodontia (Marsupialia) based on sequences for five nuclear genes.
PMID 19249373·Mol Phylogenet Evol·2009
7-preclinical
Cancer of the tonsil presenting as central nervous system metastasis: A case report.
PMID 18442058·Head Neck·2009
5-case
Dose optimization of breast balloon brachytherapy using a stepping 192Ir HDR source.
PMID 19223839·J Appl Clin Med Phys·2009
8-other
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
PMID 19608377·J Pain Symptom Manage·2009
3-trial
MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.
PMID 19289440·J Nucl Med·2009
8-other
Double dissociation of spike timing-dependent potentiation and depression by subunit-preferring NMDA receptor antagonists in mouse barrel cortex.
PMID 19363149·Cereb Cortex·2009
7-preclinical
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
PMID 18635320·Int J Radiat Oncol Biol Phys·2009
8-other
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
PMID 18927342·J Nucl Med·2008
7-preclinical
A timescale and phylogeny for "bandicoots" (Peramelemorphia: Marsupialia) based on sequences for five nuclear genes.
PMID 18328736·Mol Phylogenet Evol·2008
7-preclinical
Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment.
PMID 18355979·Int J Radiat Oncol Biol Phys·2008
4-observational
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
PMID 18487568·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5171 S COTTONWOOD ST STE 400
SALT LAKE CITY, UT 84107 - Phone
- (801) 507-3500
Quick Facts
- NPI
- 1518303569
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile